- Home
- AMD vs AZN Comparison
AMD vs AZN Comparison
Compare AMD & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMD | AZN |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.8B | 276.3B |
| IPO Year | 1972 | 1993 |
Fundamental Metrics
Financial Performance| Metric | AMD | AZN |
|---|---|---|
| Price | $210.13 | $89.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 36 | 2 |
| Target Price | ★ $240.03 | N/A |
| AVG Volume (30 Days) | ★ 39.6M | 5.6M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | ★ 78.78 | 45.02 |
| EPS | 2.02 | ★ 6.02 |
| Revenue | $32,027,000,000.00 | ★ $58,127,000,000.00 |
| Revenue This Year | $33.22 | $11.33 |
| Revenue Next Year | $30.85 | $6.08 |
| P/E Ratio | $104.50 | ★ $14.93 |
| Revenue Growth | ★ 31.82 | 13.52 |
| 52 Week Low | $76.48 | $61.24 |
| 52 Week High | $267.08 | $94.02 |
Technical Indicators
Market Signals| Indicator | AMD | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 52.24 |
| Support Level | $217.91 | $89.70 |
| Resistance Level | $224.84 | $91.66 |
| Average True Range (ATR) | 8.19 | 1.30 |
| MACD | -0.19 | -0.41 |
| Stochastic Oscillator | 51.87 | 8.55 |
Price Performance
Historical ComparisonAbout AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers (including artificial intelligence), industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. However, AMD is emerging as a prominent player in AI GPUs and related hardware. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.